Thyroid Cancer Gene Panel test | Genomic Diagnostics

Test description

RET variants and fusions, NTRK fusions, ALK fusions, and BRAF pathogenic variants are all identifiable targets for precision therapies. RET fusions in radiation-associated PTC, BRAF, RAS variants (HRAS, NRAS, KRAS) and CTNNB1 variants provide important diagnostic/prognostic information. Presence of mutation can be useful in atypical/borderline cases.

Test information

Test name

Thyroid cancer solid tumour panel

Clinical indication

Testing of thyroid cancer tumour tissue to determine specific therapy and prognosis.

‍

Gene(s)

DNA: ALK, BRAF, CTNNB1, HRAS, KRAS, NRAS

‍RNA: NTRK, ALK, RET mutation, RET fusion, NTRK fusion, ALK fusion

Method

NGS Oncomine Precision Assay

Turn around time

5 business days from receipt of sample

Medicare eligibility

N/A

Price

DNA only: $425

DNA & RNA: $799

Test request form

Somatic Genetic Testing Request Form

Sample type

FFPE Tumour Tissue

Collection type

Special instructions

6 x 5µm slides plus 1 x H&E stained slide required